产品编号：P756193
产品规格：50mg
产品价格：面议
| 标准品编号: | P756193 |
| 名称: | L-Prolyl-L-leucylglycinamide |
| 别名: | N-[1-[(Carbamoylmethyl)carbamoyl]-3-methylbutyl]-2-pyrrolidinecarboxamide; 26: PN: US6093797 PAGE: 15 claimed protein; 27: PN: US6093797 PAGE: 15 claimed protein; 2: PN: WO2009039992 PAGE: 107 claimed protein; 7-9-Oxytocin; H-Pro-Leu-Gly-NH2; L-Proline-L-leucine-glycine-amide; L-Prolyl-L-leucyl-glycine Amide; L-Prolyl-L-leucylglycylamide; MIF-1; MIF-I; MSH-release inhibiting factor I; Melanocyte-stimulating hormone release-inhibiting factor 1; Melanocyte-stimulating hormone release-inhibiting factor I; Melanocyte-stimulating hormone release-inhibiting factor I (ox); Melanostatin I (ox); Oxytocin C-terminal Tripeptide; Pro-Leu-Gly-NH2; Prolyleucyl-glycinamide; Prolylleucylglycine Amide; |
| CAS号: | 2002-44-0 |
| 分子式: | C₁₃H₂₄N₄O₃ |
| 分子量: | 284.36 |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | L-Prolyl-L-leucylglycinamide is shown to be effective in treating human depression with greater efficacy and faster onset of action than traditional anti-depressants. Also, it is used in the synthesis of novel analogs to be tested for their ability to enhance the binding of [3H]-N-propylnorapomorphine to short isoform of human dopamine D2 receptors. |
| 参考文献 | |
